ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

NCAB Honors Member Who Was In Stockholm

December 9, 1988

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB

July 23, 1993